Companies: 10,795·Total market cap: $144.5T
Ehouse Global, Inc.

Ehouse Global, Inc.

EHOSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1013
P/E Ratio
52W High$0.00001
52W Low$0.000001

Ehouse Global, Inc. (EHOS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

ehos · pe ratio · data through Dec 31, 2014

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Ehouse Global, Inc. (EHOS) measures how much investors pay for each dollar of the company's trailing earnings. EHOS's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.61.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2014-12-31

Forward P/E
N/A
EPS (TTM)
-$0.61
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Ehouse Global, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2009 – 2014 · Annual
PE Ratio (TTM)
5Y Avg 0.0x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Ehouse Global, Inc.
Ehouse Global, Inc.You
EHOS
$0MN/A-$0.61
Black Bird Biotech, Inc.
Black Bird Biotech, Inc.
BBBT
$0MN/A-$0.01
Braxia Scientific Corp.
Braxia Scientific Corp.
BRAXF
$0MN/A-$0.06
GB Sciences, Inc.
GB Sciences, Inc.
GBLX
$0MN/A-$0.00
GlobeStar Therapeutics Corporation
GlobeStar Therapeutics Corporation
GSTC
$0MN/A-$0.00
Hard to Treat Diseases Inc.
Hard to Treat Diseases Inc.
HTDS
$0MN/A
IR Biosciences Holdings Inc.
IR Biosciences Holdings Inc.
IRBS
$0MN/A-$0.31

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2014-12-31Latest
FY2014
$-0.61
2013-12-31
FY2013
$-0.27
2012-12-31
FY2012
$-0.03
2011-12-31
FY2011
$-0.01
2010-12-31
FY2010
0.01x$0.01
2009-12-31
FY2009
$-0.01

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Ehouse Global, Inc. (EHOS) measures how much investors pay for each dollar of the company's trailing earnings. EHOS's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.61.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.61 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

EHOS pe ratio · 6 questions

EHOS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.61. Data sourced from Financial Modeling Prep via EHOS's SEC 10-K and 10-Q filings.

EHOS PE ratioWhat is EHOS PE ratioCurrent PE ratio of EHOSEHOS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Ehouse Global, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09